BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38107061)

  • 1. Survival benefits of palliative gastrectomy for gastric cancer patients with liver metastasis: a population-based propensity score-matched cohort analysis.
    Ren B; Yang Y; Lv Y; Liu K
    Front Oncol; 2023; 13():1309699. PubMed ID: 38107061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis.
    Chen X; Hu W; Huang C; Liang W; Zhang J; Wu D; Lv Z; Li Y; Luo Y; Liang Z; Wang M; Wang J; Yao X
    Int J Surg; 2020 Aug; 80():135-152. PubMed ID: 32634480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefits of palliative gastrectomy in stage IV gastric cancer: a propensity score matched analysis.
    Peng W; Ma T; Xu H; Wu Z; Wu C; Sun G
    J Gastrointest Oncol; 2020 Apr; 11(2):376-385. PubMed ID: 32399278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Gastrectomy With Chemoradiotherapy Among Stage IV Gastric Adenocarcinoma: A Population-Based Analysis.
    Li S; Zang L
    Front Oncol; 2020; 10():630. PubMed ID: 32411605
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival benefit of primary tumor resection for gastric cancer with liver metastasis: A propensity score-matched, population-based study.
    Wu J; Yu J; Chen Z; Zhu H; Zhong C; Liang Y; Mai Z; Lin Z; Wan Y; Li G
    Front Oncol; 2022; 12():1039086. PubMed ID: 36465378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative gastrectomy for metastatic gastric adenocarcinoma: A national population-based cohort study.
    Kamarajah SK; Markar SR; Phillips AW; Salti GI; Dahdaleh F; Griffiths EA
    Surgery; 2021 Dec; 170(6):1702-1710. PubMed ID: 34389165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis.
    Li CL; Tang DR; Ji J; Zang B; Chen C; Zhao JQ
    World J Clin Cases; 2020 Aug; 8(15):3230-3239. PubMed ID: 32874977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel scoring system predicting survival benefits of palliative primary tumor resection for patients with unresectable metastatic colorectal cancer: A retrospective cohort study protocol.
    Cao G; Zhou W; Chen E; Wang F; Chen L; Chen M; Zhao W; Xu J; Zhang W; Zhang G; Huang X; Song Z
    Medicine (Baltimore); 2019 Sep; 98(37):e17178. PubMed ID: 31517873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
    Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
    Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative Gastrectomy Improves the Survival of Patients with Metastatic Early-Onset Gastric Cancer: A Retrospective Cohort Study.
    An H; Wang PY; Liu YC
    Curr Oncol; 2023 Aug; 30(9):7874-7890. PubMed ID: 37754487
    [No Abstract]   [Full Text] [Related]  

  • 11. The survival benefit of palliative gastrectomy and/or metastasectomy in gastric cancer patients with synchronous metastasis: a population-based study using propensity score matching and coarsened exact matching.
    Yang LP; Wang ZX; He MM; Jin Y; Ren C; Wang ZQ; Wang FH; Li YH; Wang F; Xu RH
    J Cancer; 2019; 10(3):602-610. PubMed ID: 30719157
    [No Abstract]   [Full Text] [Related]  

  • 12. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis.
    Ebinger SM; Warschkow R; Tarantino I; Schmied BM; Güller U; Schiesser M
    Gastric Cancer; 2016 Jul; 19(3):723-34. PubMed ID: 26391158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision-making of adjuvant therapy in pT1N1M0 gastric cancer: Should radiotherapy be added to chemotherapy? A propensity score-matched analysis.
    Pan S; Yin S; Zhu Z; Liu F; Xu H
    J Cancer; 2021; 12(4):1179-1189. PubMed ID: 33442416
    [No Abstract]   [Full Text] [Related]  

  • 14. Significant Role of Palliative Gastrectomy in Selective Gastric Cancer Patients with Peritoneal Dissemination: A Propensity Score Matching Analysis.
    Nie RC; Chen S; Yuan SQ; Chen XJ; Chen YM; Zhu BY; Qiu HB; Peng JS; Chen YB
    Ann Surg Oncol; 2016 Nov; 23(12):3956-3963. PubMed ID: 27380641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study.
    Li Y; Xie D; Chen X; Hu T; Lu S; Han Y
    Technol Cancer Res Treat; 2020; 19():1533033820964131. PubMed ID: 33111644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefits of gastrectomy in gastric cancer patients with stage IV: a population-based study.
    He X; Lai S; Su T; Liu Y; Ding Y; Quan S; Si J; Sun L
    Oncotarget; 2017 Dec; 8(63):106577-106586. PubMed ID: 29290972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival benefit of surgical resection for stage IV gastric cancer: A SEER-based propensity score-matched analysis.
    Sun J; Nan Q
    Front Surg; 2022; 9():927030. PubMed ID: 36386506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis.
    Yoon YS; Kim CW; Lim SB; Yu CS; Kim SY; Kim TW; Kim MJ; Kim JC
    J Surg Oncol; 2014 Mar; 109(3):239-44. PubMed ID: 24165972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.
    Takechi H; Fujikuni N; Tanabe K; Hattori M; Amano H; Noriyuki T; Nakahara M
    BMC Gastroenterol; 2020 Aug; 20(1):256. PubMed ID: 32758144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis.
    Pausch TM; Liu X; Cui J; Wei J; Miao Y; Heger U; Probst P; Heap S; Hackert T
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.